Carcinoma, Hepatocellular Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)
Recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +12 more
2022-04-07
Apr 7, 2022
H
A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases
Active, not recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +9 more
2022-04-05
Apr 5, 2022
E
A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
Recruiting
  • Carcinoma, Hepatocellular
  • Fresno, California
  • +35 more
2022-03-31
Mar 31, 2022
U
Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy - 2021
Completed
  • Carcinoma, Hepatocellular
  • PET/CT Exam
  • Bordeaux, France
    CHU Bordeaux
2022-03-29
Mar 29, 2022
M
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
Recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +181 more
2022-03-30
Mar 30, 2022
H
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • Phoenix, Arizona
  • +118 more
2022-03-28
Mar 28, 2022
T
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
Recruiting
  • Carcinoma, Hepatocellular
  • Metastatic Liver Cancer
  • BioTraceIO Lite
  • Phoenix, Arizona
  • +5 more
2022-03-23
Mar 23, 2022
E
Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea
Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
2022-03-21
Mar 21, 2022
H
A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation
Active, not recruiting
  • Carcinoma, Hepatocellular
  • Duarte, California
  • +150 more
2022-03-17
Mar 17, 2022
H
A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista
Active, not recruiting
  • Carcinoma, Hepatocellular
  • Napoli, Campania, Italy
  • +20 more
2022-03-16
Mar 16, 2022
G
Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Recruiting
  • Carcinoma, Hepatocellular
  • Cirrhosis, Liver
    • Los Angeles, California
    • +19 more
    2022-03-14
    Mar 14, 2022
    E
    A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants
    Active, not recruiting
    • Liver Neoplasms
    • Carcinoma, Hepatocellular
    • Non-interventional
    • Cheonan, Chungcheongnam-do, Korea, Republic of
    • +41 more
    2022-03-14
    Mar 14, 2022
    H
    A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy
    Recruiting
    • Carcinoma, Hepatocellular
    • Elche, Alicante, Spain
    • +26 more
    2022-03-11
    Mar 11, 2022
    C
    A Study on the Angioarchitecture of Hepatocellular Carcinoma
    Recruiting
    • Carcinoma, Hepatocellular
    • embolization
    • Hong Kong, Hong Kong
      Department of Imaging and Interventional Radiology, Prince of Wa
    2022-03-10
    Mar 10, 2022
    B
    Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
    Active, not recruiting
    • Carcinoma, Hepatocellular
    • Los Angeles, California
    • +6 more
    2022-03-10
    Mar 10, 2022
    C
    Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma
    Recruiting
    • Carcinoma, Hepatocellular
    • Ablative chemoembolization (ACE)
    • Hong Kong, Hong Kong
      Department of Imaging and Interventional Radiology, Prince of Wa
    2022-03-10
    Mar 10, 2022
    E
    A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma - 2022
    Completed
    • Carcinoma, Hepatocellular
    • +3 more
    • Osaka, Japan
    • +1 more
    2022-03-07
    Mar 7, 2022
    M
    Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
    Active, not recruiting
    • Hepatitis B
    • +2 more
      • Rochester, Minnesota
        Mayo Clinic
      2022-03-04
      Mar 4, 2022
      M
      Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma - 2020
      Completed
      Has Results
      • Carcinoma, Hepatocellular
      • Tepotinib 300 mg
      • +4 more
      • Beijing, Beijing, China
      • +42 more
      2021-12-16
      Dec 16, 2021
      M
      Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)
      Active, not recruiting
      • Carcinoma, Hepatocellular
      • pembrolizumab
      • +2 more
      • Hefei, Anhui, China
      • +40 more
      2022-03-03
      Mar 3, 2022
      E
      A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC
      Recruiting
      • Carcinoma, Hepatocellular
      • Bangalore, Karnataka, India
      • +8 more
      2022-02-07
      Feb 7, 2022
      C
      CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
      Recruiting
      • HER2-positive
      • +30 more
      • CT-0508
      • Duarte, California
      • +4 more
      2022-02-01
      Feb 1, 2022
      G
      HR Versus RFA for HCC in Patients With PHT
      Recruiting
      • Carcinoma, Hepatocellular
      • +2 more
      • Hepatic Resection
      • Radiofrequency Ablation
      • Nanning, Guangxi, China
        Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
      2022-01-14
      Jan 14, 2022
      U
      Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion
      Recruiting
      • Carcinoma, Hepatocellular
      • Idarubicin and Lipiodol
      • Angers, France
      • +3 more
      2021-12-24
      Dec 24, 2021
      M
      Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)
      Active, not recruiting
      • Carcinoma, Hepatocellular
      • Tucson, Arizona
      • +171 more
      2021-12-23
      Dec 23, 2021